Canadian National Vaccine Safety (CANVAS) Network
|
|
- Marcia Ross
- 6 years ago
- Views:
Transcription
1 Canadian National Vaccine Safety (CANVAS) Network Julie A. Bettinger Vaccine Evaluation Center, BC Children s Hospital University of British Columbia
2 Disclosure Statement Disclosure of Relationship I am a member of an Advisory Board or equivalent with a commercial organization. I am a member of a Speaker Bureau. I have received payment from a commercial organization (including gifts or other consideration or in kind compensation). I hold a patent for a product referred to in the CME/CPD program or that is marketing by a commercial organization I hold a patent for a product referred to in the CME/CPD program or that is marketing by a commercial organization I hold investments in a pharmaceutical organization, medical devices company or communications firms. I am currently participating in or have participated in a clinical trial within the past two years. Company/Organization Medicago N/A N/A N/A N/A N/A N/A
3 CANVAS: Vaccine Safety Surveillance Objective: To develop a feasible and inexpensive methodology capable of providing early safety data to public health authorities for seasonal influenza vaccines, pandemic influenza vaccine and other new vaccines (meningococcal B vaccine) in various age groups
4 CANVAS: Vaccine Safety Surveillance Developed a network of >20,000 participants Online survey at various time points to measure safety of seasonal influenza vaccines each year Includes control group of ~10,000 unvaccinated participants to enable background rate calculations for common events
5 Background Since 2009 web-based active safety surveillance of vaccinated health care workers across Canada : Online survey at day 8, day 29 and 6 months after immunization 2010: Online survey day 8 and day : Measured background rates for events. Control survey administered 7-14 days prior to influenza vaccination program start 2012: Added telephone follow up for non-responders. Pilot tested surveillance in parents of vaccinated children : Expanded to vaccinated adults and children 1. De Serres et al. Plos One;2012:7(7 e38563). 2. Bettinger et al. PIDJ 2014;33:
6 Background 2014: Surveillance in 5 provinces at 7 main sites BC, AB, QC, ON and NS 4 public health sub sites in Ontario and BC Pharmacies in ON, BC and NS Developed mobile safety application ( app ) which enables smart phone use Influenza safety surveillance adapted to monitor safety of meningococcal B vaccine program in Quebec
7 Methods Active recruitment at clinics Collect participant details at time of immunization Online registration (at clinic or home) Participant enters details via survey website
8
9 Methods Online consent
10 Methods Background rates/control group Previous year s participants ed notice to start monitoring health ~2 weeks prior to vaccination programs Background health event survey ed Reminder Severe events followed up by telephone
11 Methods Severe health events: Cause work/school/daycare absenteeism Prevent daily activities Cause a health care visit
12 Methods Online survey collects information on local reactions, systemic symptoms, allergic symptoms and other health events
13 Methods Online survey collects information on local reactions, systemic symptoms, allergic symptoms and other health events
14 Methods: allergic symptoms and other health events
15 Methods Online reported Health Events or AEFI followed up by nurses for event details within hrs.
16 Methods If signal identified ability for additional enhanced follow up: existing consent
17
18 Signal Detection 2012 October 2012 Italian and Canadian authorities suspend Agriflu use CANVAS ONLY safety information on Agriflu vaccine available in Canada at that time First safety data available Oct. 22 Full analysis of safety information to PHAC by Oct Agriflu vaccinees, 1253 other influenza vacinees and 3260 unimmunized participants No safety signal detected Vaccine suspension lifted Oct. 30
19 Results 2013 Enrolled 21,669 vaccinees: 61% response rate (N=13,127) 1459 (11%) parents of children 6 months-16 years 11,668 adults Enrolled 13,622 controls: 50% response rate (N=6763) 855 (13%) parents of children 6 months-16 years 5,908 adults
20 CANVAS: Weekly Results Nov. 4, 2014 CONTROLS (non-vaccinated group) 7/7 sites have collected information on the nonvaccinated group (controls) 8476 responded to 8 day survey 7639 adults and 837 children 349 reported a severe health issue in last 7 days 4.1% background event rate 95.9% no events
21 CANVAS: Weekly Results Nov. 4, 2014 VACCINEES 10,920 vaccinated participants enrolled 7/7 sites enrolling 5/7 have reached 8 day reporting period on first group enrolled 1 site has completed enrollment 4454 responded to 8-day survey 193 reported a severe health issue in last 7 days 4.3% event rate 95.7% no events
22 CANVAS: 2014 What we can provide: Vaccinees Table 1: CANVAS AEFI Reported as of November 11, 2014 FPT AB BC ON NS QC Total AEFI Total Severe* Hospitali Febrile reported AEFIs zations ED Anaphylaxis Seizure Seizure ORS Vaccine type in ORS cases =agriflu; 1=flumist; 4=fluviral =agriflu =agriflu; 1=vaxigrip, 2=To be confirmed =agriflu total=7 agriflu; 1=flumist; 1=vaxigrip; 4=fluviral, 2=to be TOTAL confirmed *Severe defined as work/school absenteeism/prevent daily activities/seek health care 1 anaphylaxis case was given Fluviral
23 CANVAS: 2014 What we can provide: Controls Table 1: CANVAS AE Reported as of November 11, 2014 FPT AB BC ON NS QC Total AE Total Hospitaliza Febrile reported Severe* AE tions ED Anaphylaxis Seizure Seizure ORS TOTAL *Severe defined as work/school absenteeism/prevent daily activities/seek health care
24 Online survey acceptable to majority of participants (91%) I think that it's good that you are making an effort to gather information in a formalized manner. With the introduction of Flumist to the younger target group, it's good to get feedback on what happens after the kids/youth left the clinic. Thank you.
25
26 CANVAS: Next Steps Developed AEFI app for apple and android phones Ability for notifications/reminders Ability to collect data at multiple time points (eg 48, 72 hours and 29 days after immunization)
27 CANVAS: Next Steps Developed AEFI app for apple and android phones Ability for spontaneous reporting
28 CANVAS: App Beta Test Beta testing app this fall: live and simulated stream Live Stream: 71 enrolled in live stream; 36 downloaded app 16 completed 8 day survey Simulated Stream: Test AEFI reporting mechanism for severe event
29 CANVAS: Next Steps Starting in 2015 European regulatory authorities will drop requirement for pre-licensure clinical trials for seasonal influenza vaccines Recommend enhanced surveillance Ability to rapidly detect clinically significant change Need for control group for background rates Not expected to identify rare event Recommendations very similar to CANVAS CANVAS produced a report for EMA on 2014 seasonal vaccines
30 CANVAS: Next Steps Enhanced surveillance for mass immunization programs of new vaccines CANVAS site in Quebec currently monitoring safety of MenB vaccine Potential to augment CANVAS app with bar code scanning Identify based on vaccine lot Canada will be first country licensed to use Fluad in children in 2015 Ability to provide rapid safety data on this product
31 CANVAS Investigators Influenza Surveillance Mobile Safety App Louis Valiquette Centre Hospitalier Uni. de Sherbrooke Gaston De Serres Centre Hospitalier Uni. de Québec Ann McCarthy Ottawa Hospital Brenda Coleman Mount Sinai Hospital Shelly McNeil Queen Elizabeth II Health Sciences Centre Otto Vanderkooi Alberta Children s Hospital Karina Top and Jennifer Isnor Canadian Center for Vaccinology Kumanan Wilson and Dean Fergusson, Ottawa Hospital Research Institute Shelley Deeks and Natasha Crowcroft, Public Health Ontario CANVAS app developed by Sigvaria Mobile Technologies, Inc.
Canadian National Vaccine Safety (CANVAS) Network: Active Safety Surveillance for Influenza Vaccine, 2013 and 2014
Canadian National Vaccine Safety (CANVAS) Network: Active Safety Surveillance for Influenza Vaccine, 2013 and 2014 Julie A. Bettinger Vaccine Evaluation Center, BC Children s Hospital University of British
More informationInvasive Meningococcal Disease in Canada: Identifying Research Priorities by Virtual Round Table
Invasive Meningococcal Disease in Canada: Identifying Research Priorities by Virtual Round Table Simon Dobson, Gordean Bjornson, David Scheifele, Julie Bettinger, Natasha Crowcroft, Philippe De Wals, Raymond
More informationsafety and for safety assessment as required by the European Medicines Agency in 2015.
Surveillance and outbreak reports Successful methodology for large-scale surveillance of severe events following influenza vaccination in Canada, 2011 and 2012 J A Bettinger (jbettinger@cfri.ca) 1, I Rouleau
More informationEllen MacDonald on behalf of
Ellen MacDonald on behalf of S McNeil, A McGeer, J McElhaney, J Johnstone, V Shinde, D MacKinnon-Cameron, L Ye, A Ambrose and M Andrew on behalf of the Public Health Agency of Canada/Canadian Institutes
More informationCost-Effectiveness of Quadrivalent vs Monovalent Vaccination against Meningococcal Disease in Canada
Cost-Effectiveness of Quadrivalent vs Monovalent Vaccination against Meningococcal Disease in Canada Derek Weycker, Ph.D. 1 Mark Atwood, M.S. 1 Thomas E. Delea, M.S.I.A. 1 Anoush Youssoufian, B.A. 1 Dion
More informationShelly A McNeil, MD on behalf of the SOS Network of the Canadian Immunization Research Network (CIRN) CIC 2016 Dec 6-8, 2016 Ottawa, ON
Resource Utilization and Cost of Laboratory Confirmed Influenza Requiring Hospitalization in Canadian Adults A Study from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research
More informationVol. 20 Weekly issue July 2015
Europe s journal on infectious disease epidemiology, prevention and control Vol. 20 Weekly issue 29 23 July 2015 SURVEILLANCE AND OUTBREAK REPORTS Successful methodology for large-scale surveillance of
More informationINFORMATION AND CONSENT FORM
INFORMATION AND CONSENT FORM A RANDOMIZED CONTROLLED TRIAL TO COMPARE THE IMMUNOGENICITY OF SELF- ADMINISTERED AND NURSE-ADMINISTERED INTRADERMAL INFLUENZA VACCINE Investigators Dr. Shelly McNeil Queen
More informationVaccine Safety: Its everyone s business! PHO Rounds: Nov 19, 2013
Vaccine Safety: Its everyone s business! PHO Rounds: Nov 19, 2013 Tara Harris, Nurse Consultant Shelley Deeks, Medical Director Immunization and Vaccine Preventable Diseases 1 Learning objectives 1. Describe
More informationPublic Health Physicians and Vaccine Safety
Public Health Physicians and Vaccine Safety PHO Rounds January 21, 2013 Shelley Deeks, Medical Director Tara Harris, Nurse Consultant Immunization and Vaccine Preventable Diseases Outline and objectives
More informationPreferential LAIV use in children with chronic underlying conditions?
Preferential LAIV use in children with chronic underlying conditions? Caroline Quach, MD MSc FRCPC Pediatric ID Consultant & Medical Microbiologist The Montreal Children s Hospital Associate Professor
More informationManitoba Influenza Surveillance Report
Manitoba Influenza Surveillance Report 212/213 Season Summary: Week 47: Nov 18-24, 212 The influenza-like-illness rate was 4.8% with 5% of sentinel physician sites reporting. There was one case of influenza
More informationFecal shedding of rotavirus vaccine in premature babies in the neonatal unit
Fecal shedding of rotavirus vaccine in premature babies in the neonatal unit Dr. Manish Sadarangani Director, Vaccine Evaluation Center, BC Children s Hospital Research Institute Assistant Professor, Division
More informationVACCINOLOGY RESEARCH SYMPOSIUM In celebration of Dr. David Scheifele s Research Career
Nov 5, 2015 THU 0800-1815 Nov 6, 2015 FRI 0830-1330 Child & Family Research Institute Chan Auditorium 950 West 28th Ave Vancouver, BC V5Z 4H4 VACCINOLOGY RESEARCH SYMPOSIUM In celebration of Dr. David
More informationNovember 9 to 15, 2014 (week 46)
Hanks you November 9 to 15, 2014 (week 46) Overall Summary In week 46, overall influenza activity increased from the previous week with sporadic activity reported in six provinces and one territory. Low-level
More informationWhat's New With The Flu. Claire Farella RN BScN MN Manager Community Health Protection
What's New With The Flu Claire Farella RN BScN MN Manager Community Health Protection Historical Data 100 anniversary of the Spanish Flu - H1N1 500 million infected world wide with 50-100 million deaths-
More informationOngoing Circulation of Swine-Origin Influenza A/H1N1 in BC
Travis Hottes, Naveed Janjua, & Danuta Skowronski Number 23: Weeks 2-22 BCCDC Influenza & Emerging Respiratory Pathogens Team May 17 June 6, 29 Ongoing Circulation of Swine-Origin Influenza A/H1N1 in BC
More informationSampling Methodology
Background CCMTA s Drugs and Driving Framework identified need to raise public s awareness regarding risks associated with drug-impaired driving Purpose of Survey: To determine drivers knowledge, perceptions,
More informationInfluenza Vaccine Fact Sheet 2010/2011
Influenza Vaccine Fact Sheet 2010/2011 This fact sheet provides basic information only. It must not take the place of medical advice, diagnosis or treatment. Always talk to a healthcare professional about
More informationVaccine Safety Monitoring for ph1n pandemic vaccine:
Vaccine Safety Monitoring for ph1n1 2009 pandemic vaccine: lessons learned in British Columbia 2011: Eighth Annual Bi-National Cross Border Workshop Pacific Northwest Border Health Alliance Monika Naus
More informationInfluenza and the Flu Shot Facts for Health Care Workers
Influenza and the Flu Shot Facts for Health Care Workers 2014-2015 Presentation to (group name) Your Name Your Title Date Influenza Facts o Highly contagious and common respiratory illness caused by influenza
More informationManitoba Influenza Surveillance Report
Manitoba Influenza Surveillance Report 2012/2013 Season Week 14 Mar 31 Apr 6, 2013 Mar 31 - Apr 6: The proportion of patients visiting sentinel physicians for influenza-likeillness was 11% (up from 0%
More informationManitoba Influenza Surveillance Report 2012/2013 Season
Week 11 Mar 10-16, 2013 Manitoba Influenza Surveillance Report 2012/2013 Season Mar 10-16: The proportion of patients visiting sentinel physicians for influenza-likeillness was 2.5% (down from 7.8% last
More informationMeningococcal Education Program for Quebec Physicians: How Results Have Changed 2 Years after the Initial Program
Meningococcal Education Program for Quebec Physicians: How Results Have Changed 2 Years after the Initial Program Marc H. Lebel, MD, FRCPC John Yaremko, MD, FRCPC Anne Dionne, MD, FRCPC Anne-Julie Gaudreau,
More informationInfluenza. Influenza vaccines (WHO position paper) Weekly Epid. Record (2005, 80: ) 287
Program Management 82_19 SAGE encouraged all countries to consider their preparedness for a potential influenza pandemic, recognizing that it would occur before strain-specific vaccine can be made in significant
More informationPathways to Immunization Policy in Canada
Pathways to Immunization Policy in Canada hollygrahamwikispaces.com Noni MacDonald MD, MSc, FRCPC 1 Rhonda Kropp BScN, MPH 2 Karina Top MD, MS, FRCPC 1 1. Dalhousie University, Canadian Centre for Vaccinology,
More informationManitoba Health, Healthy Living and Seniors (MHHLS) Week 9 (Feb.28 Mar.5, 2016) == Severe outcomes associated with. == Cases and cumulative incidence
Manitoba Health, Healthy Living and Seniors (MHHLS) Influenza Surveillance `Week 215 216 53: Dec 28, 214 Jan 3, 215 Week 9 (Feb.28 Mar.5, 216) Data extracted Mar. 11, 216 at 11: am Laboratory-confirmed
More informationOverview. Ontario Public Drug Programs, Ministry of Health and Long-Term Care
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Frequently Asked Questions for Pharmacists October 2015 Pharmacist Administration of the Publicly Funded Influenza Vaccine and Claims
More informationTo view an archived recording of this presentation please click the following link:
To view an archived recording of this presentation please click the following link: http://pho.adobeconnect.com/pipr4mxgx1rb/ Please scroll down this file to view a copy of the slides from the session.
More informationHealth Canada Endorsed Important Safety Information on Infanrix Hexa
Health Canada Endorsed Important Safety Information on Infanrix Hexa October 30, 2012 Dear Health Care Professional: Subject: Voluntary recall of GlaxoSmithKline (GSK) Infanrix Hexa Vaccine Lot A21CB242A
More informationWEEKLY NEW BRUNSWICK INFLUENZA REPORT Reporting period: October 9, 2011 October 15, 2011 (week 41)
WEEKLY NEW BRUNSWICK INFLUENZA REPORT Reporting period: October 9, 211 October 15, 211 (week 41) Summary In New Brunswick, low influenza activity for week 41 and within expected levels New Brunswick: There
More informationH1N Influenza Q & A With a Focus on Panvax
November 6, 2009 1 of 5 H1N1-2009 Influenza Q & A With a Focus on Panvax 1. What H1N1 vaccines are available in Canada? The vaccines available in Canada to protect against H1N1-2009 influenza are: Arepanrix
More informationFluSafe: Tool for Tracking Healthcare Worker Immunizations in IIS
FluSafe: Tool for Tracking Healthcare Worker Immunizations in IIS Aaron Bieringer Data Quality Analyst, MIIC Program September 20, 2012 Outline FluSafe Overview Current Process Proposed Enhancements Next
More informationStrategies to increase the uptake of the influenza vaccine by healthcare workers: A summary of the evidence
Strategies to increase the uptake of the influenza vaccine by healthcare workers: A summary of the evidence This evidence summary document has been prepared for the National Collaborating Centres for Public
More informationRecent trends in medical cannabis use in Canada
Recent trends in medical cannabis use in Canada Paul Grootendorst Faculty of Pharmacy, University of Toronto Department of Economics, McMaster University Cannabis therapeutic effects Cannabis has been
More informationImmunization with Influenza Vaccine (Inf)
Immunization with Influenza Vaccine (Inf) Background Influenza is a respiratory infection caused by either the type A or type B influenza viruses, and occurs in populations worldwide. Although it is generally
More information12 to 18 January, 2014 (Week 03)
Hanks you 12 to 18 January, 2014 (Week 03) Overall Summary In week 03, overall laboratory detections of influenza decreased slightly, reflecting decreased activity in some regions that experienced an earlier
More informationABCs of AEFIs: An approach to adverse events following immunization for primary care providers
ABCs of AEFIs: An approach to adverse events following immunization for primary care providers Karina Top, MD, MS, FRCPC Associate Professor of Pediatrics and Community Health & Epidemiology Dalhousie
More informationHow do I comply with the Influenza Control Program Policy this year?
Influenza Control Program Frequently Asked Questions Influenza Vaccine Influenza or the flu can be a serious contagious disease, which is spread by droplet transmission through close contact with an infected
More informationNew Mexico Retiree Health Care Authority Medicare Part D Prescription Drug Program Express Scripts Holding Company. All Rights Reserved.
New Mexico Retiree Health Care Authority Medicare Part D Prescription Drug Program 1 About Express Scripts Express Scripts is RHCA s chosen partner for administering your prescription plan We are a leading
More informationInfluenza Activity Levels Decline while Detections of Swine-Origin Influenza A/H1N1 Continue in BC
8-9 UPDATE Travis Hottes, Naveed Janjua, & Danuta Skowronski Number 22: Weeks 17-19 BCCDC Influenza & Emerging Respiratory Pathogens Team April 26 May 16, 9 Influenza Activity Levels Decline while Detections
More informationHow do I comply with the Influenza Control Program Policy this year?
Influenza Control Program Frequently Asked Questions Influenza Vaccine Influenza or the flu can be a serious contagious disease, which is spread by droplet transmission through close contact with an infected
More informationWeek 43 (Oct , 2016)
Manitoba Health, Seniors and Active Living (MHSAL) Laboratory-confirmed influenza cases this week: Influenza A cases: 3 Influenza B cases: Since Sept. 1, 216: Influenza A cases: 8 Influenza B cases: 1
More informationLa vaccination universelle contre la grippe
La vaccination universelle contre la grippe Allison McGeer, MSc, MD Mount Sinai Hospital, Toronto 6 es Journées annuelles de santé publique Évaluation des technologies et prise de décision en vaccination
More informationOntario Public Drug Programs, Ministry of Health and Long-Term Care. For the Influenza Immunization Season
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Notice from the Executive Officer: Pharmacist Administration of Publicly Funded Influenza Vaccines and Claims Submission using the Health
More informationInfluenza Vaccine Safety Monitoring Update
Influenza Vaccine Safety Monitoring Update Advisory Committee on Immunization Practices October 28, 2010 Tom Shimabukuro, MD, MPH, MBA Immunization Safety Office Division of Healthcare Quality Promotion,
More informationDecember 3 to 9, 2017 (Week 49)
Hanks you December 3 to 9, 2017 (Week 49) Overall Summary Overall, Influenza activity continues to increase across Canada; however many indicators such as hospitalizations, outbreaks and geographic spread
More informationWestern Canadian Immunization Forum 2011 Perspectives on Evaluating Immunization Programs
Western Canadian Immunization Forum 2011 Perspectives on Evaluating Immunization Programs David Scheifele MD Carol LaJeunesse RN, BScN Vaccine Evaluation Center, Vancouver Conflict of Interest Disclosures
More informationCommunity Influenza Surveillance Report Update of Current Status January 24, 2018
2017-2018 Community Influenza Surveillance Report Update of Current Status January 24, 2018 Overall assessment Influenza activity, particularly influenza B, continues to be high in the Middlesex-London
More informationInfluenza Season: Our Annual Epidemic
2016-2017 Influenza Season: Our Annual Epidemic Kieran Moore AMOH KFLA Piotr Oglaza PHPM Resident KFLA October 2016 Working together for better health Acknowledgements Dr Bryna Warshawsky Public Health
More informationH1N1 FEARS EXAGGERATED SAY MANY CANADIANS LIBS TEN PERCENTAGE POINTS BEHIND TORIES
www.ekospolitics.ca H1N1 FEARS EXAGGERATED SAY MANY CANADIANS LIBS TEN PERCENT POINTS BEHIND TORIES [Ottawa November 12, 20] More than half of Canadians say that the high level of public concern over H1N1
More informationCanadian Immunization Research Workshop
Canadian Immunization Research Workshop March 25, 2013 Ottawa, ON Meeting Report Written by: Jennifer Raven, PhD, Associate, Strategic Initiatives, CIHR-III Desktop Publishing: Diane Christin, Project
More informationNATIONAL ADVISORY COMMITTEE ON IMMUNIZATION: 50 TH ANNIVERSARY. Dr. Bryna Warshawsky (Chair )
NATIONAL ADVISORY COMMITTEE ON IMMUNIZATION: 50 TH ANNIVERSARY Dr. Bryna Warshawsky (Chair 2011-2014) Disclosure Statement I have no affiliation (financial or otherwise) with a pharmaceutical, medical
More informationPhysiotherapists in Canada, 2011 National and Jurisdictional Highlights
pic pic pic Physiotherapists in Canada, 2011 National and Jurisdictional Highlights Spending and Health Workforce Our Vision Better data. Better decisions. Healthier Canadians. Our Mandate To lead the
More informationAdministration of Publicly-Funded Influenza Vaccine by Pharmacists for Influenza Season
AUGUST 2014 Administration of Publicly-Funded Influenza Vaccine by Pharmacists for 2014-15 Influenza Season Administration of Publicly-Funded Influenza Vaccine by Pharmacists for 2014-15 Influenza Season
More informationANNEX B INFLUENZA PANDEMIC PLANNING CONSIDERATIONS IN ON RESERVE FIRST NATIONS COMMUNITIES
Assembly of First Nations Assemblée des Premières Nations 1 ANNEX B INFLUENZA PANDEMIC PLANNING CONSIDERATIONS IN ON RESERVE FIRST NATIONS COMMUNITIES Presented by the Assembly of First Nations (Kim Barker),
More informationThis Frequently Asked Questions document contains various aspects of UIIP in the following sections. Overview Eligibility...
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Frequently Asked Questions for Pharmacists October 2017: Pharmacist Administration of the Publicly Funded Influenza Vaccine and Claims
More informationA BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS
Pharmacy Benefact A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS Number 757 September 2018 Alberta Public Health Activities Program (APHAP) Influenza Immunization Program 2018/2019 This
More informationNovember 5 to 11, 2017 (Week 45)
Hanks you Overall Summary November 5 to 11, 2017 (Week 45) Influenza activity crossed the seasonal threshold in week 45, indicating the beginning of the influenza season at the national level. The number
More informationHPV Immunization, Canadian Perspective
HPV Immunization, Canadian Perspective Mahnaz FarhangMehr Interim Director, Immunization Division Center for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada Outline Background,
More informationNo Laboratory-confirmed Influenza Activity
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2018 2019 53: Dec 28, 2014 Jan 3, 2015 No Laboratory-confirmed Influenza Activity Week 38 39 (Sep. 16 29, 2018) Data
More informationH1N1 Update. Arizona Department of Health Services Bureau of Public Health Emergency Preparedness. Teresa Ehnert Bureau Chief
H1N1 Update Arizona Department of Health Services Bureau of Public Health Emergency Preparedness Teresa Ehnert Bureau Chief H1N1 Update Current Status of Virus Status of Vaccine Other Planning Activities
More informationPrince Edward Island Chronic Obstructive Pulmonary Disease (COPD) Trends
Prince Edward Island Chronic Obstructive Pulmonary Disease (COPD) Trends 2001-2011 December 2014 Population Health Assessment and Surveillance Unit, Chief Public Health Office, Department of Health and
More informationFlu Vaccine Access Via Pharmacy Vaccine Network
Re: Flu Vaccine Access Via Pharmacy Vaccine Network Effective 9/15/2016, IEHP Medi-Cal and Medicare DualChoice Cal MediConnect (IEHP Direct) Members who are over 18 years old may obtain Flu Vaccines through
More informationLow Influenza Activity
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2018 2019 53: Dec 28, 2014 Jan 3, 2015 Low Influenza Activity Week 45 (Nov. 4 10, 2018) Data extracted Nov. 16, 2018
More informationNo vaccine trade names are discussed. only)
Prospective evaluation of diphtheria-tetanus-acellular pertussis-polio-haemophilus influenzae type b (DTaP- IPV-Hib) and pneumococcal vaccination in children who completed chemotherapy for acute lymphocytic
More informationMexico. Figure 1: Confirmed cases of A[H1N1] by date of onset of symptoms; Mexico, 11/07/2009 (Source: MoH)
Department of International & Tropical diseases In order to avoid duplication and to make already verified information available to a larger audience, this document has been adapted from an earlier version
More informationLow Influenza Activity
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2018 2019 53: Dec 28, 2014 Jan 3, 2015 Low Influenza Activity Week 40 41 (Sept. 30 Oct. 13, 2018) Data extracted Oct.
More informationSEASONAL INFLUENZA VACCINE INFORMATION FOR IMMUNIZATION PROVIDERS
2015-2016 SEASONAL INFLUENZA VACCINE INFORMATION FOR IMMUNIZATION PROVIDERS Office of the Chief Medical Officer of Health Communicable Disease Control Branch Immunization Program August 2015 Table of Contents
More informationApril 8 to April 14, 2012 (Week 15)
Hanks you April 8 to April 14, 212 (Week 15) Overall Influenza Summary The peak of activity for the 211-212 influenza season in Canada has passed as most indicators of influenza activity continue to decline.
More informationCanadian Immunization Conference 2018 Dec 4
Enveloped Virus-Like Particle (evlp) Cytomegalovirus (CMV) Vaccine is immunogenic and safe: preliminary results of a First-in-Humans Canadian Immunization Network (CIRN) Clinical Trials Network (CTN) -
More informationImplementing BC s Influenza Prevention Policy
Implementing BC s Influenza Prevention Policy A survey of healthcare facilities Alexandra Nunn 1, Audrey C. Campbell 1, Monika Naus 1,2, Jeffrey C. Kwong 2, David Puddicombe 1, Meena Dawar 3, Susan Quach
More informationUpdate on safety of pandemic influenza A (H1N1) vaccines
Update on safety of pandemic influenza A (H1N1) vaccines Dr David Wood Department of Immunization Vaccines and Biologicals Quality, safety and standards SAGE 28 October 2009 Context of vaccine safety discussions
More informationPostmarketing Surveillance of Annual Influenza Vaccines: Extended Vaccine Safety
Postmarketing Surveillance of Annual Influenza Vaccines: Extended Vaccine Safety Background Trivalent inactivated influenza vaccines have been used for decades in Canada and are considered safe and effective.
More informationReport from the National Diabetes Surveillance System:
Report from the National Diabetes Surveillance System: Diabetes in Canada, 28 To promote and protect the health of Canadians through leadership, partnership, innovation and action in public health. Public
More informationRoutine Immunization Schedules. Section 2. Newfoundland and Labrador Immunization Manual. Routine Immunization Schedules
Newfoundland and Labrador Immunization Manual Section 2... 2.1 Routine and Delayed Immunization Schedules for Infants and Children... 2.2 Recommended Immunizations for Adults... 2.3 (Provinces and Territories)...
More informationPoison Control Centres
Poison Control Centres Monica Durigon Field Epidemiologist Public Health Agency of Canada Joanne Stares Public Health Officer Public Health Agency of Canada Placement site: BC Centre for Disease Control
More informationSCHOOL-BASED IMMUNIZATION COVERAGE IN NOVA SCOTIA: to
Health and Wellness SCHOOL-BASED IMMUNIZATION COVERAGE IN NOVA SCOTIA: 2008-09 to 2011-12 May 23, 2013 Population Health Assessment and Surveillance Acknowledgements Provincial surveillance of school-based
More informationLow Influenza Activity
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2018 2019 53: Dec 28, 2014 Jan 3, 2015 Low Influenza Activity Week 46 (Nov. 11 17, 2018) Data extracted Nov. 23, 2018
More informationHigh Activity. Since Sept. 1, 2018: Hospitalizations: 62 ICU* admissions: 8 Deaths: <5. Syndromic in Community Syndromic in Care Syndromic in ED
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2018 2019 53: Dec 28, 2014 Jan 3, 2015 High Activity Week 51 (Dec.16 22, 2018) Data extracted Dec. 28, 2018 at 11:00
More informationPost Licensure Communication on Vaccine Safety among Regulator, Industry and Stakeholder
Post Licensure Communication on Vaccine Safety among Regulator, Industry and Stakeholder Lucky S Slamet DCVMN International Annual General Meeting, New Delhi, India, 8-10 July 2014 1 Disclaimer The information
More informationHow do I comply with the Influenza Control Program Policy this year?
Influenza Control Program Frequently Asked Questions Influenza Vaccine Influenza or the flu can be a serious contagious disease, which is spread by droplet transmission through close contact with an infected
More informationCurrent Assessment of Influenza Activity in Waterloo Region. Influenza Activity: August 28, 2016 to October 22, 2016 (Weeks 35 to 42)
Region of Waterloo Public Health and Emergency Services Local Influenza Surveillance Bulletin Released October 31, 2016 Current Assessment of Influenza Activity in Waterloo Region As of October 31, 2016,
More informationIMMUNIZATION IN PREGNANCY
IMMUNIZATION IN PREGNANCY Dr. Chelsea Elwood, B.M.ScH, M.Sc, MD,FRCSC Reproductive Infectious Diseases Fellow Department of Obstetrics and Gynecology University of British Columbia cnelwood@cw.bc.ca Disclosure
More informationWorkshop Hands on - Steroid Injections. Michael Stein MDCM, FRCP(C) Date: Nov
Workshop Hands on - Steroid Injections Michael Stein MDCM, FRCP(C) Date: Nov 26 2018 Disclosure of Commercial Support This program has received no financial support Faculty/Presenter Disclosures I am a
More informationTABLE D-1 POST-M.D. TRAINEES EXITING QUEBEC TRAINING PROGRAMS IN JULY, 2014 AT THE COMPLETION OF POST-M.D. TRAINING
TABLE D-1 Family Medicine Emergency Medicine (CFPC) Care of the Elderly (CFPC) Enhanced Skills: Fam. Med. Training FAMILY MEDICINE SUBTOTAL Anesthesiology Critical Care (Anes.) Public Health and Preventive
More informationPOST-M.D. TRAINEES EXITING ALBERTA TRAINING PROGRAMS IN JULY, 2015 AT THE COMPLETION OF POST-M.D
TABLE D-1 Family Medicine Emergency Medicine (CFPC) Care of the Elderly (CFPC) Enhanced Skills: Fam. Med. Training FAMILY MEDICINE SUBTOTAL Anesthesiology Public Health and Preventive Medicine Dermatology
More informationInfluenza Activity Continues to be Sporadic in BC
BRITISH COLUMBIA (BC) INFLUENZA SURVEILLANCE 8-9 UPDATE Travis Hottes, Naveed Janjua, & Danuta Skowronski Number 5: Weeks 51 and 52 BCCDC Influenza & Emerging Respiratory Pathogens Team Dec 14 27, 8 Influenza
More informationSchool-based HPV Immunisation Programs: The WA Experience
School-based HPV Immunisation Programs: The WA Experience Professor Paul Effler, MD, MPH, FAFPHM Medical Coordinator, Prevention and Control Program Communicable Disease Control Directorate WA School Based
More informationGeographic Location, Field of Post-M.D. Training
TABLE D-1 Family Medicine Emergency Medicine (CFPC) Care of the Elderly (CFPC) Enhanced Skills: Fam. Med. Training FAMILY MEDICINE SUBTOTAL Anesthesiology Critical Care (Anes.) Public Health and Preventive
More information* Rates were not calculated due to small numbers.
Manitoba Health, Healthy Living and Seniors (MHHLS) Influenza Surveillance `Week 215 216 53: Dec 28, 214 Jan 3, 215 Week 48 (Nov.29 Dec.5, 215) Data extracted Dec.11, 215 at 11: am Laboratory-confirmed
More informationData sharing in Canada through the COGR:
Data sharing in Canada through the COGR: a unified clinical genome database as a community resource for standardizing and sharing genetic interpretations Dr. Matthew Lebo, Kathleen-Rose Zakoor, Dr. Jordan
More informationWHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES
WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES Immunization and vaccine development in the last decade Since the Millennium Summit in 2000, immunization substantial international
More informationINFLUENZA IN CANADA SEASON
FAX FAX FAX FAX Contained in this FAX issue: (No. of pages: 6) Vol. 23 24 INFLUENZA IN CANADA 1996-1997 SEASON................ F-1 185-192 Date of publication: 15 December 1997 Official page numbers: For
More informationGOVERNMENT OF ALBERTA. Alberta s Plan for Pandemic Influenza
GOVERNMENT OF ALBERTA Alberta s Plan for Pandemic Influenza November 2003 What is pandemic influenza? The word pandemic is used to describe diseases that cause worldwide outbreaks of illness involving
More informationMDPH Influenza Update
Massachusetts Department of Public Health Bureau of Infectious Disease and Laboratory Sciences MDPH Influenza Update 9-27-2018 Joyce Cohen, MPH Influenza Coordinator MA Department of Public Health MDPH
More informationUnadjuvanted H1N Influenza Vaccine Fact Sheet for Pregnant Women
1 of 5 Unadjuvanted H1N1-2009 Influenza Vaccine Fact Sheet for Pregnant Women This fact sheet provides basic information only. It must not take the place of medical advice, diagnosis or treatment. Always
More informationOntario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario
Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario Views expressed in the attached document do not necessarily represent those of the Ministry of Health and Long Term Care or those
More informationA cost comparison of electronic and hybrid data collection systems in Ontario during pandemic and seasonal influenza vaccination campaigns
RESEARCH ARTICLE Open Access A cost comparison of electronic and hybrid data collection systems in Ontario during pandemic and seasonal influenza vaccination campaigns Jennifer A Pereira 1, Julie Foisy
More informationBackground Paper for the OTDT Committees
Background Paper for the OTDT Committees Organs and Tissues Donation and Transplantation (OTDT) Listing of Key Government Reports Contents 1. Introduction... 2 A. Background... 2 2. Public Recommendation
More information